Niva Bupa
Niva Bupa is an Indian health insurance company controlled by the international healthcare group Bupa.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Niva Bupa Health Insurance Company Limited is an Indian health insurance company headquartered in New Delhi. The business operates under the Niva Bupa brand and is part of Bupa, a UK-based health insurance and healthcare group. Its core activity is the provision and distribution of health insurance policies in India, supported by agents and bancassurance partners. The company was established in 2008 as a 74:26 joint venture between Max India and Bupa. Although the joint venture was created in 2008, operations began in 2010 under the Max Bupa Health Insurance name. This structure combined Max India's Indian business presence with Bupa's experience in health insurance and healthcare. During its early operating period, the company developed distribution through individual agents and bank-related insurance partnerships, channels that are important in India's insurance market. Ownership changed progressively over the following decade. In 2015, Bupa increased its stake to 49% by acquiring a further 23% from Max India for ₹191 crore. In February 2019, Max India's remaining 51% interest was acquired by Fettle Tone LLP, an affiliate of the Indian private equity firm True North, for ₹510 crore. The transaction ended Max India's direct ownership of the insurer while leaving Bupa as a significant shareholder. The ownership balance shifted again in 2023 when True North announced an agreement to sell a 20% stake to Bupa for ₹2,700 crore. Following that transaction, Bupa became the majority shareholder with a 63% holding. The company subsequently adopted the Niva Bupa identity, replacing the earlier Max Bupa branding and reflecting its closer connection with the Bupa group. Niva Bupa entered the public markets in November 2024 through an initial public offering and became listed on India's National Stock Exchange and BSE. Bupa remained the company's sole promoter after the offering and retained more than 55% ownership. The listing marked a further stage in the company's development from a joint venture into a publicly traded Indian health insurer with majority ownership by an international healthcare group. The company is regulated by the Insurance Regulatory and Development Authority of India. Its public corporate history includes a 2016 regulatory penalty of ₹20 lakh imposed by IRDAI for four violations, including an issue concerning timelines for settling claims. This regulatory event is part of the documented compliance history of the insurer and does not change its stated status as an active company. Niva Bupa's positioning is centered on health insurance for the Indian market, with distribution based on a combination of agency and bancassurance channels. Publicly available reference material identifies the company at the insurer level rather than providing a complete, current catalogue of individual policies in the supplied sources; consequently, individual product names, detailed benefits, premiums, and current management information are not stated here.
History
Niva Bupa was established in India in 2008 as a joint venture between Max India and Bupa, with the initial ownership split at 74% for Max India and 26% for Bupa. The company began operating in 2010 under the name Max Bupa Health Insurance. Its initial business model relied on the distribution of health insurance policies through agents and bancassurance partners. Bupa expanded its interest in 2015 by purchasing an additional 23% from Max India for ₹191 crore, taking its holding to 49%. In February 2019, Max India's entire remaining 51% stake was acquired by Fettle Tone LLP, an affiliate of the Indian private equity firm True North, for ₹510 crore. This transaction changed the ownership structure while preserving Bupa's participation as a major shareholder. In 2023, True North announced that it would sell a 20% stake to Bupa for ₹2,700 crore. The transaction made Bupa the majority owner with a 63% shareholding and preceded the company's transition to the Niva Bupa identity. The rebranding connected the Indian insurer more directly with the Bupa group while retaining its focus on the Indian health insurance market. Niva Bupa entered the public market in November 2024 through an initial public offering, after which its shares were listed on the National Stock Exchange of India and BSE. Bupa remained the sole promoter and held more than 55% of the company after the IPO. The listing represented a new ownership and governance phase for a company that had developed from a strategic joint venture into a publicly traded insurer. The company is regulated by the Insurance Regulatory and Development Authority of India. Its documented regulatory history includes a ₹20 lakh penalty imposed in 2016 for four violations, one involving the prescribed timing of claim settlements. Beyond this event, the supplied reference material does not provide detailed information about later enforcement actions, executive appointments, product-level developments, or financial performance. Niva Bupa is therefore best understood from the available record as an active, India-based health insurer operating within the Bupa group and serving the market through agency and bancassurance distribution.
- 2024
Initial public offering and stock-market listing
[1]Niva Bupa went public in November and listed on India's National Stock Exchange and BSE, while Bupa retained majority ownership.
- 2023
Bupa became the majority shareholder
[1]Bupa agreed to acquire 20% from True North, taking its reported ownership to 63%.
- 2019
True North affiliate acquired Max India's remaining interest
[1]Fettle Tone LLP acquired Max India's 51% stake for ₹510 crore in February 2019.
- 2015
Bupa increased its ownership to 49%
[1]Bupa acquired a further 23% stake from Max India for ₹191 crore.
- 2010
Operations began under the Max Bupa name
[1]The company started operating as Max Bupa Health Insurance and distributed policies through agents and bancassurance partners.
- 2008
Company established as a Max India–Bupa joint venture
[1]The insurer was founded with Max India holding 74% and Bupa holding 26%.
Products and positioning
An India-focused health insurance company combining Bupa's international healthcare and insurance association with local distribution through agents and bancassurance partners.
Health insurance
Health insurance policies
Niva Bupa's core offering is health insurance for customers in India. The supplied reference material describes the business at company level rather than identifying individual current policy names or specifying benefits, exclusions, premiums, or coverage limits. Policies have historically been distributed through the company's agents and bancassurance partners.
Controversies
Brand decisions
2024
Niva Bupa completed its initial public offeringOtherBackground
Following the change in control and brand identity, the company pursued a public-market listing in India.
Action taken
The insurer went public in November 2024 and listed on the National Stock Exchange of India and BSE.
Aftermath
Bupa remained the sole promoter and retained more than 55% ownership after the IPO.
2023
Bupa agreed to acquire a further 20% stakeM&ABackground
True North held the principal Indian shareholder position after acquiring Max India's remaining interest.
Action taken
Bupa announced the purchase of a 20% stake from True North for ₹2,700 crore, taking its reported ownership to 63%.
Aftermath
Bupa became the majority shareholder and the company's ownership became more closely aligned with the Bupa group.
Acquisition consideration. ₹2,700 crore (2023)
2019
True North affiliate acquired Max India's remaining stakeM&ABackground
Max India continued to hold 51% of the insurer after Bupa's 2015 purchase.
Action taken
Fettle Tone LLP, an affiliate of True North, acquired Max India's entire 51% interest for ₹510 crore.
Aftermath
Max India exited the ownership structure and True North became the Indian private-equity shareholder.
Acquisition consideration. ₹510 crore (February 2019)
2015
Bupa purchased an additional 23% stakeM&ABackground
Bupa held 26% of the joint venture at formation and sought a larger ownership position.
Action taken
Bupa acquired a further 23% from Max India for ₹191 crore, raising its holding to 49%.
Aftermath
Bupa became an equal minority partner with a substantially larger stake, while Max India retained the balance until 2019.
Acquisition consideration. ₹191 crore (2015)
Recent events
Max Bupa Health Insurance rebrands as Niva Bupa[2]
Reported:
Max Bupa Health Insurance announced that it had rebranded itself as Niva Bupa. The company said the change followed a change in shareholding, with Max India exiting and private equity firm True North entering.
Max Bupa appoints Krishnan Ramachandran as MD and CEO[3]
Reported:
Max Bupa Health Insurance said it appointed Krishnan Ramachandran as its new managing director and chief executive officer, succeeding Ashish Mehrotra.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/niva-bupa · Editorial policy · How profiles are compiled